Proton Therapy Offers New Hope for Patients with Glioblastoma
New NRG Oncology trial shows promising survival benefit, now advancing to Phase III A new national study led by NRG Oncology is bringing renewed hope to patients diagnosed with glioblastoma (GBM)— one of the most aggressive and difficult brain cancers to treat. The findings, recently published by Bioengineer.org and presented at the ASTRO Annual Meeting in San Francisco, showed that patients […]
Read More